Atıf Formatları
Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. Sütçü Et Al. , "Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study," Frontiers in Pediatrics , vol.12, 2024

Sütçü, M. Et Al. 2024. Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study. Frontiers in Pediatrics , vol.12 .

Sütçü, M., Kara, M., Yıldız, F., KILIÇ, Ö., TURAL KARA, T., Akkoc, G., ... BÜYÜKCAM, A.(2024). Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study. Frontiers in Pediatrics , vol.12.

Sütçü, Murat Et Al. "Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study," Frontiers in Pediatrics , vol.12, 2024

Sütçü, Murat Et Al. "Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study." Frontiers in Pediatrics , vol.12, 2024

Sütçü, M. Et Al. (2024) . "Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study." Frontiers in Pediatrics , vol.12.

@article{article, author={Murat Sütçü Et Al. }, title={Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study}, journal={Frontiers in Pediatrics}, year=2024}